VGLL4 and colorectal carcinoma: Similar results were observed by using a new inhibitory peptide (Super-TDU), which mimics the VGLL4 to disrupt the YAP-TEAD interaction and showed antitumor activity in CRC models31,32 (Figure S8a–c).